EBUS-TBNA: A high-yield diagnostic procedure for benign and malignant aetiologies

G L Calligaro


EBUS in combination with EBUS-TBNA has become an essential tool for diagnosing and staging patients with suspected non-small-cell lung cancer (NSCLC), with a diagnostic accuracy superior to more traditional invasive modalities such as mediastinoscopy, and a much better safety profile. 

Author's affiliations

G L Calligaro, Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, Groote Schuur Hospital, University of Cape Town Lung Institute, Cape Town, South Africa

Full Text:

PDF (55KB)

Cite this article

African Journal of Thoracic and Critical Care Medicine 2022;28(1):8.

Article History

Date submitted: 2022-05-04
Date published: 2022-05-05

Article Views

Abstract views: 301
Full text views: 204


  • There are currently no refbacks.

African Journal of Thoracic and Critical Care Medicine| Online ISSN: 2617-0205

This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) | Read our privacy policy.

Our Journals: South African Medical Journal | African Journal of Health Professions Education | South African Journal of Bioethics and Law | South African Journal of Child Health | Southern African Journal of Critical Care | African Journal of Thoracic and Critical Care MedicineSouth African Journal of Obstetrics and Gynaecology |